{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:40:11Z","timestamp":1792978811725,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05700-7","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:17:48Z","timestamp":1769033868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitochondrial Dynamics-Related Gene Regulation by Epigenetic Suppression of GCN5 Exerts Neuroprotective Effects in Rotenone-Induced Parkinson\u2019s Disease Model"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1750-8209","authenticated-orcid":false,"given":"G\u00f6k\u00e7e Ceren","family":"Ku\u015f\u00e7u","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6104-175X","authenticated-orcid":false,"given":"Ezgi","family":"Tut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0266-2115","authenticated-orcid":false,"given":"\u00c7evik","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-6616","authenticated-orcid":false,"given":"Aylin","family":"Buhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-0965","authenticated-orcid":false,"given":"\u00d6zg\u00fcn Selim","family":"Germiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-4520","authenticated-orcid":false,"given":"\u00c7\u0131\u011f\u0131r","family":"Biray Avc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4945-4794","authenticated-orcid":false,"given":"Cem","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-9690","authenticated-orcid":false,"given":"Ebru","family":"\u015eanc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-0184","authenticated-orcid":false,"given":"Nefise \u00dclk\u00fc","family":"Karabay Yava\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-1637","authenticated-orcid":false,"given":"Altu\u011f","family":"Yava\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"5700_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/NEUROLINT16030037","volume":"16","author":"E Bej","year":"2024","unstructured":"Bej E, Cesare P, Volpe AR et al (2024) Oxidative stress and neurodegeneration: insights and therapeutic strategies for Parkinson\u2019s disease. Neurol Int 16:502\u2013517. https:\/\/doi.org\/10.3390\/NEUROLINT16030037","journal-title":"Neurol Int"},{"key":"5700_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/S12035-025-04727-6","author":"RM Merghany","year":"2025","unstructured":"Merghany RM, El-Sawi SA, Naser AFA et al (2025) Pelargonium graveolens attenuates rotenone-induced Parkinson\u2019s disease in a rat model: role of MAO-B inhibition and in silico study. Mol Neurobiol. https:\/\/doi.org\/10.1007\/S12035-025-04727-6","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5700_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G et al (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):1\u201316. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"issue":"18","key":"5700_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-023-00676-7","volume":"181","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF (2023) Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential. Mol Neurodegener 181(18):1\u201320. https:\/\/doi.org\/10.1186\/S13024-023-00676-7","journal-title":"Mol Neurodegener"},{"key":"5700_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol 24:103\u2013116. https:\/\/doi.org\/10.5607\/en.2015.24.2.103","journal-title":"Exp Neurobiol"},{"key":"5700_CR6","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.3233\/JAD-220449","volume":"94","author":"KP Tryphena","year":"2023","unstructured":"Tryphena KP, Anuradha U, Kumar R et al (2023) Understanding the involvement of microRNAs in mitochondrial dysfunction and their role as potential biomarkers and therapeutic targets in Parkinson\u2019s disease. J Alzheimers Dis 94:S187\u2013S202. https:\/\/doi.org\/10.3233\/JAD-220449","journal-title":"J Alzheimers Dis"},{"issue":"20","key":"5700_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS252010982","volume":"25","author":"P Miziak","year":"2024","unstructured":"Miziak P, Baran M, Borkiewicz L et al (2024) Acetylation of histone H3 in cancer progression and prognosis. Int J Mol Sci 25(20):10982. https:\/\/doi.org\/10.3390\/IJMS252010982","journal-title":"Int J Mol Sci"},{"key":"5700_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/JOF10080522","volume":"10","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhou Y, Liu Y et al (2024) Research progress on the mechanism and function of histone acetylation regulating the interaction between pathogenic fungi and plant hosts. J Fungi 10:522. https:\/\/doi.org\/10.3390\/JOF10080522","journal-title":"J Fungi"},{"key":"5700_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.292","volume":"4","author":"R Liu","year":"2023","unstructured":"Liu R, Wu J, Guo H et al (2023) Post-translational modifications of histones: mechanisms, biological functions, and therapeutic targets. MedComm 4:e292. https:\/\/doi.org\/10.1002\/mco2.292","journal-title":"MedComm"},{"key":"5700_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/FNAGI.2022.1025473","volume":"14","author":"F Kabir","year":"2023","unstructured":"Kabir F, Atkinson R, Cook AL et al (2023) The role of altered protein acetylation in neurodegenerative disease. Front Aging Neurosci 14:1025473. https:\/\/doi.org\/10.3389\/FNAGI.2022.1025473","journal-title":"Front Aging Neurosci"},{"key":"5700_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.NEULET.2016.05.060","volume":"627","author":"KG Gebremedhin","year":"2016","unstructured":"Gebremedhin KG, Rademacher DJ (2016) Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex. Neurosci Lett 627:121\u2013125. https:\/\/doi.org\/10.1016\/J.NEULET.2016.05.060","journal-title":"Neurosci Lett"},{"key":"5700_CR12","doi-asserted-by":"publisher","unstructured":"Sugeno N, J\u00e4ckel S, Voigt 1A et al (2016) \u03b1-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses. Sci Reports 61 6:1\u201311. https:\/\/doi.org\/10.1038\/srep36328","DOI":"10.1038\/srep36328"},{"key":"5700_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13024-021-00450-7\/FIGURES\/6","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker L, Tran GT, Sundaresan J et al (2021) Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol Neurodegener 16:1\u201320. https:\/\/doi.org\/10.1186\/S13024-021-00450-7\/FIGURES\/6","journal-title":"Mol Neurodegener"},{"key":"5700_CR14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/S00702-018-1902-4\/FIGURES\/7","volume":"125","author":"YK Ryu","year":"2018","unstructured":"Ryu YK, Park HY, Go J et al (2018) Effects of histone acetyltransferase inhibitors on l-DOPA-induced dyskinesia in a murine model of Parkinson\u2019s disease. J Neural Transm 125:1319\u20131331. https:\/\/doi.org\/10.1007\/S00702-018-1902-4\/FIGURES\/7","journal-title":"J Neural Transm"},{"key":"5700_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2023.114835","volume":"165","author":"HT Xiao","year":"2023","unstructured":"Xiao HT, Jin J, Zheng ZG (2023) Emerging role of GCN5 in human diseases and its therapeutic potential. Biomed Pharmacother 165:114835. https:\/\/doi.org\/10.1016\/J.BIOPHA.2023.114835","journal-title":"Biomed Pharmacother"},{"key":"5700_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBAGRM.2020.194626","volume":"1864","author":"B Mutlu","year":"2021","unstructured":"Mutlu B, Puigserver P (2021) GCN5 acetyltransferase in cellular energetic and metabolic processes. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1864:194626. https:\/\/doi.org\/10.1016\/J.BBAGRM.2020.194626","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"5700_CR17","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1074\/JBC.M113.521641","volume":"289","author":"I Scott","year":"2014","unstructured":"Scott I, Webster BR, Chan CK et al (2014) GCN5-like protein 1 (GCN5L1) controls mitochondrial content through coordinated regulation of mitochondrial biogenesis and mitophagy. J Biol Chem 289:2864\u20132872. https:\/\/doi.org\/10.1074\/JBC.M113.521641","journal-title":"J Biol Chem"},{"key":"5700_CR18","doi-asserted-by":"publisher","first-page":"21379","DOI":"10.1074\/jbc.M109.018911","volume":"284","author":"P Wareski","year":"2009","unstructured":"Wareski P, Vaarmann A, Choubey V et al (2009) PGC-1\u03b1 and PGC-1\u03b2 regulate mitochondrial density in neurons. J Biol Chem 284:21379\u201321385. https:\/\/doi.org\/10.1074\/jbc.M109.018911","journal-title":"J Biol Chem"},{"key":"5700_CR19","doi-asserted-by":"publisher","first-page":"9461","DOI":"10.18632\/aging.103219","volume":"12","author":"F Fan","year":"2020","unstructured":"Fan F, Li S, Wen Z et al (2020) Regulation of PGC-1\u03b1 mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson\u2019s disease. Aging Albany NY 12:9461\u20139474. https:\/\/doi.org\/10.18632\/aging.103219","journal-title":"Aging Albany NY"},{"key":"5700_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-pharmtox-010715-103633","volume":"56","author":"ML Bobbin","year":"2016","unstructured":"Bobbin ML, Rossi JJ (2016) RNA interference (RNAi)-based therapeutics: delivering on the promise? Annu Rev Pharmacol Toxicol 56:103\u2013122. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103633","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5700_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00126","volume":"9","author":"J-Y Lin","year":"2017","unstructured":"Lin J-Y, Xie C-L, Zhang S-F et al (2017) Current experimental studies of gene therapy in Parkinson\u2019s disease. Front Aging Neurosci 9:126. https:\/\/doi.org\/10.3389\/fnagi.2017.00126","journal-title":"Front Aging Neurosci"},{"key":"5700_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70088","volume":"30","author":"X-Y Yao","year":"2024","unstructured":"Yao X-Y, Cao B-E, Liu J-Y et al (2024) Microglial melatonin receptor 1 degrades pathological alpha-synuclein through activating LC3-associated phagocytosis in vitro. CNS Neurosci Ther 30:e70088. https:\/\/doi.org\/10.1111\/cns.70088","journal-title":"CNS Neurosci Ther"},{"key":"5700_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6847971","author":"M Gharbavi","year":"2018","unstructured":"Gharbavi M, Amani J, Kheiri-Manjili H et al (2018) Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. https:\/\/doi.org\/10.1155\/2018\/6847971","journal-title":"Adv Pharmacol Sci"},{"key":"5700_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/PHARMACEUTICS11020055","volume":"11","author":"X Ge","year":"2019","unstructured":"Ge X, Wei M, He S, Yuan WE (2019) Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics 11:55. https:\/\/doi.org\/10.3390\/PHARMACEUTICS11020055","journal-title":"Pharmaceutics"},{"key":"5700_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2024.117210","volume":"178","author":"Y Chen","year":"2024","unstructured":"Chen Y, Dai R, Cheng M et al (2024) Status and role of the ubiquitin\u2013proteasome system in renal fibrosis. Biomed Pharmacother 178:117210. https:\/\/doi.org\/10.1016\/J.BIOPHA.2024.117210","journal-title":"Biomed Pharmacother"},{"key":"5700_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2024.1519649","author":"AA Revankar","year":"2024","unstructured":"Revankar AA, Patil AS, Karishetti R et al (2024) Enhanced bioavailability of quercetin-loaded niosomal in situ gel for the management of Parkinson\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2024.1519649","journal-title":"Front Pharmacol"},{"key":"5700_CR27","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1166\/jnn.2017.13799","volume":"17","author":"MS Gunay","year":"2017","unstructured":"Gunay MS, Ozer AY, Erdogan S et al (2017) Development of nanosized, pramipexole-encapsulated liposomes and niosomes for the treatment of Parkinson\u2019s disease. J Nanosci Nanotechnol 17:5155\u20135167. https:\/\/doi.org\/10.1166\/jnn.2017.13799","journal-title":"J Nanosci Nanotechnol"},{"key":"5700_CR28","doi-asserted-by":"publisher","unstructured":"Weinert M, Selvakumar T, Tierney TS, Alavian KN (2015) Isolation, culture and long-term maintenance of primary mesencephalic dopaminergic neurons from embryonic rodent brains. J Vis Exp 52475. https:\/\/doi.org\/10.3791\/52475","DOI":"10.3791\/52475"},{"key":"5700_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041120","volume":"7","author":"MM Daadi","year":"2012","unstructured":"Daadi MM, Grueter BA, Malenka RC et al (2012) Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson\u2019s disease. PLoS One 7:e41120. https:\/\/doi.org\/10.1371\/journal.pone.0041120","journal-title":"PLoS One"},{"issue":"2","key":"5700_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16020223","volume":"16","author":"S Liga","year":"2024","unstructured":"Liga S, Paul C, Moac\u0103 EA, P\u00e9ter F (2024) Niosomes: composition, formulation techniques, and recent progress as delivery systems in cancer therapy. Pharmaceutics 16(2):223. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16020223","journal-title":"Pharmaceutics"},{"key":"5700_CR31","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2217\/NNM.13.155","volume":"8","author":"O Paecharoenchai","year":"2013","unstructured":"Paecharoenchai O, Teng L, Yung BC et al (2013) Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine 8:1865\u20131873. https:\/\/doi.org\/10.2217\/NNM.13.155","journal-title":"Nanomedicine"},{"key":"5700_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/J.IJBIOMAC.2019.07.003","volume":"137","author":"H Moulahoum","year":"2019","unstructured":"Moulahoum H, Sanli S, Timur S, Zihnioglu F (2019) Potential effect of carnosine encapsulated niosomes in bovine serum albumin modifications. Int J Biol Macromol 137:583\u2013591. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2019.07.003","journal-title":"Int J Biol Macromol"},{"key":"5700_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2024.106243","volume":"101","author":"E Tut","year":"2024","unstructured":"Tut E, Guldu OK, Medine EI (2024) Antitumor properties of bromelain loaded trastuzumab conjugated niosomes in HER2+ breast cancer cells. J Drug Deliv Sci Technol 101:106243. https:\/\/doi.org\/10.1016\/J.JDDST.2024.106243","journal-title":"J Drug Deliv Sci Technol"},{"key":"5700_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10856-007-3193-4","volume":"19","author":"Y Huang","year":"2008","unstructured":"Huang Y, Chen J, Chen X et al (2008) PEGylated synthetic surfactant vesicles (niosomes): novel carriers for oligonucleotides. J Mater Sci Mater Med 19:607\u2013614. https:\/\/doi.org\/10.1007\/s10856-007-3193-4","journal-title":"J Mater Sci Mater Med"},{"key":"5700_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.IJPHARM.2012.03.003","volume":"428","author":"T Endres","year":"2012","unstructured":"Endres T, Zheng M, Beck-Broichsitter M, Kissel T (2012) Lyophilised ready-to-use formulations of PEG-PCL-PEI nano-carriers for siRNA delivery. Int J Pharm 428:121\u2013124. https:\/\/doi.org\/10.1016\/J.IJPHARM.2012.03.003","journal-title":"Int J Pharm"},{"key":"5700_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.YMETH.2021.05.004","volume":"199","author":"Y Thabet","year":"2022","unstructured":"Thabet Y, Elsabahy M, Eissa NG (2022) Methods for preparation of niosomes: a focus on thin-film hydration method. Methods 199:9\u201315. https:\/\/doi.org\/10.1016\/J.YMETH.2021.05.004","journal-title":"Methods"},{"key":"5700_CR37","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/21691401.2018.1489271","volume":"47","author":"M Hemati","year":"2019","unstructured":"Hemati M, Haghiralsadat F, Yazdian F et al (2019) Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artif Cells Nanomed Biotechnol 47:1295\u20131311. https:\/\/doi.org\/10.1080\/21691401.2018.1489271","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"5700_CR38","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/mds.25978","volume":"29","author":"JM Cooper","year":"2014","unstructured":"Cooper JM, Wiklander PBO, Nordin JZ et al (2014) Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29:1476\u20131485. https:\/\/doi.org\/10.1002\/mds.25978","journal-title":"Mov Disord"},{"key":"5700_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"5700_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N du Percie Sert","year":"2020","unstructured":"du Percie Sert N, Hurst V, Ahluwalia A et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410","journal-title":"PLoS Biol"},{"key":"5700_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-10-4","volume":"10","author":"Y Chen","year":"2015","unstructured":"Chen Y, Zhang DQ, Liao Z et al (2015) Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson\u2019s disease. Mol Neurodegener 10:1\u201314. https:\/\/doi.org\/10.1186\/1750-1326-10-4","journal-title":"Mol Neurodegener"},{"key":"5700_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3\u201333. https:\/\/doi.org\/10.1016\/S0014-2999(03)01272-X","journal-title":"Eur J Pharmacol"},{"key":"5700_CR43","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/284472a0","volume":"284","author":"PR Sanberg","year":"1980","unstructured":"Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284:472\u2013473. https:\/\/doi.org\/10.1038\/284472a0","journal-title":"Nature"},{"key":"5700_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41598-021-81097-8","volume":"11","author":"J Leslie","year":"2021","unstructured":"Leslie J, Robinson SM, Oakley F, Luli S (2021) Non-invasive synchronous monitoring of neutrophil migration using whole body near-infrared fluorescence-based imaging. Sci Rep 11:1415. https:\/\/doi.org\/10.1038\/s41598-021-81097-8","journal-title":"Sci Rep"},{"key":"5700_CR45","volume-title":"The rat brain in stereotaxic coordinates, Fifth Edit","author":"G Paxinos","year":"2005","unstructured":"Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, Fifth Edit. Elsevier, San Diego, CA, USA"},{"key":"5700_CR46","doi-asserted-by":"publisher","DOI":"10.3791\/57648","author":"K Young","year":"2018","unstructured":"Young K, Morrison H (2018) Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Vis Exp. https:\/\/doi.org\/10.3791\/57648","journal-title":"J Vis Exp"},{"key":"5700_CR47","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X (2013) An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 3:71\u201385","journal-title":"Biostat Bioinforma Biomath"},{"key":"5700_CR48","doi-asserted-by":"publisher","first-page":"e2570","DOI":"10.1038\/cddis.2016.465","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Ma S, Xia Y et al (2017) Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim. Cell Death Dis 8:e2570\u2013e2570. https:\/\/doi.org\/10.1038\/cddis.2016.465","journal-title":"Cell Death Dis"},{"key":"5700_CR49","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.3892\/mmr.2018.9606","volume":"18","author":"XJ Ning","year":"2018","unstructured":"Ning XJ, Yan X, Wang YF et al (2018) Parkin deficiency elevates hepatic ischemia\/reperfusion injury accompanying decreased mitochondrial autophagy, increased apoptosis, impaired DNA damage repair and altered cell cycle distribution. Mol Med Rep 18:5663\u20135668. https:\/\/doi.org\/10.3892\/mmr.2018.9606","journal-title":"Mol Med Rep"},{"key":"5700_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01225","volume":"10","author":"L Zhou","year":"2019","unstructured":"Zhou L, Zhang L, Zhang Y et al (2019) PINK1 deficiency ameliorates cisplatin-induced acute kidney injury in rats. Front Physiol 10:1225. https:\/\/doi.org\/10.3389\/fphys.2019.01225","journal-title":"Front Physiol"},{"key":"5700_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/md19040182","author":"SH Son","year":"2021","unstructured":"Son SH, Lee SM, Lee MH et al (2021) Omega-3 fatty acids upregulate SIRT1\/3, activate PGC-1\u03b1 via deacetylation, and induce Nrf1 production in 5\/6 nephrectomy rat model. Mar Drugs. https:\/\/doi.org\/10.3390\/md19040182","journal-title":"Mar Drugs"},{"key":"5700_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/mus.20976","volume":"37","author":"MJ Drummond","year":"2008","unstructured":"Drummond MJ, Glynn EL, Lujan HL et al (2008) Gene and protein expression associated with protein synthesis and breakdown in paraplegic skeletal muscle. Muscle Nerve 37:505\u2013513. https:\/\/doi.org\/10.1002\/mus.20976","journal-title":"Muscle Nerve"},{"key":"5700_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/J.NEUROPHARM.2016.04.025","volume":"108","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Chen S, Yu S et al (2016) Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson\u2019s disease. Neuropharmacology 108:238\u2013251. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2016.04.025","journal-title":"Neuropharmacology"},{"key":"5700_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ageing\/afx196","volume":"47","author":"C McDonald","year":"2018","unstructured":"McDonald C, Gordon G, Hand A et al (2018) 200 years of Parkinson\u2019s disease: what have we learnt from James Parkinson? Age Ageing 47:209\u2013214. https:\/\/doi.org\/10.1093\/ageing\/afx196","journal-title":"Age Ageing"},{"key":"5700_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2023.105140","volume":"86","author":"TM Tassew","year":"2023","unstructured":"Tassew TM, Xuan N, Chai B (2023) PDDS: a software for the early diagnosis of Parkinson\u2019s disease from MRI and DaT scan images using detection and segmentation algorithms. Biomed Signal Process Control 86:105140. https:\/\/doi.org\/10.1016\/j.bspc.2023.105140","journal-title":"Biomed Signal Process Control"},{"key":"5700_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2023.1105247","volume":"17","author":"MS Karvandi","year":"2023","unstructured":"Karvandi MS, Sheikhzadeh Hesari F, Aref AR, Mahdavi M (2023) The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: the role of ER stress, oxidative stress, and neuroinflammation. Front Cell Neurosci 17:1105247. https:\/\/doi.org\/10.3389\/FNCEL.2023.1105247","journal-title":"Front Cell Neurosci"},{"key":"5700_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-023-03553-8","volume":"13","author":"H Adam","year":"2023","unstructured":"Adam H, Gopinath SCBB, Md Arshad MK et al (2023) An update on pathogenesis and clinical scenario for Parkinson\u2019s disease: diagnosis and treatment. 3 Biotech 13:142. https:\/\/doi.org\/10.1007\/s13205-023-03553-8","journal-title":"3 Biotech"},{"key":"5700_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/J.YMTHE.2025.03.030","author":"S Szunyogh","year":"2025","unstructured":"Szunyogh S, Carroll E, Wade-Martins R (2025) Recent developments in gene therapy for Parkinson\u2019s disease. Mol Ther. https:\/\/doi.org\/10.1016\/J.YMTHE.2025.03.030","journal-title":"Mol Ther"},{"key":"5700_CR59","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1002\/MED.21718","volume":"40","author":"D Li","year":"2020","unstructured":"Li D, Mastaglia FL, Fletcher S, Wilton SD (2020) Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson\u2019s disease in the precision medicine era. Med Res Rev 40:2650\u20132681. https:\/\/doi.org\/10.1002\/MED.21718","journal-title":"Med Res Rev"},{"key":"5700_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/nano7040077","volume":"7","author":"K Tatiparti","year":"2017","unstructured":"Tatiparti K, Sau S, Kashaw S, Iyer A (2017) SiRNA delivery strategies: a comprehensive review of recent developments. Nanomaterials 7:77. https:\/\/doi.org\/10.3390\/nano7040077","journal-title":"Nanomaterials"},{"key":"5700_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","volume":"144","author":"Y Dong","year":"2019","unstructured":"Dong Y, Siegwart DJ, Anderson DG (2019) Strategies, design, and chemistry in siRNA delivery systems. Adv Drug Deliv Rev 144:133\u2013147. https:\/\/doi.org\/10.1016\/j.addr.2019.05.004","journal-title":"Adv Drug Deliv Rev"},{"key":"5700_CR62","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/pharmaceutics17030287","volume":"17","author":"M Lens","year":"2025","unstructured":"Lens M (2025) Niosomes as vesicular nanocarriers in cosmetics: characterisation, development and efficacy. Pharmaceutics 17:287. https:\/\/doi.org\/10.3390\/pharmaceutics17030287","journal-title":"Pharmaceutics"},{"key":"5700_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.07.050","volume":"530","author":"FE Abdelrahman","year":"2017","unstructured":"Abdelrahman FE, Elsayed I, Gad MK et al (2017) Response surface optimization, ex vivo and in vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm 530:1\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.050","journal-title":"Int J Pharm"},{"key":"5700_CR64","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jps.23867","volume":"103","author":"AS Zidan","year":"2014","unstructured":"Zidan AS, Habib MJ (2014) Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels. J Pharm Sci 103:952\u2013964. https:\/\/doi.org\/10.1002\/jps.23867","journal-title":"J Pharm Sci"},{"key":"5700_CR65","doi-asserted-by":"publisher","first-page":"19494","DOI":"10.1021\/acsami.8b05513","volume":"10","author":"C Yang","year":"2018","unstructured":"Yang C, Gao S, Song P et al (2018) Theranostic niosomes for efficient siRNA\/microRNA delivery and activatable near-infrared fluorescent tracking of stem cells. ACS Appl Mater Interfaces 10:19494\u201319503. https:\/\/doi.org\/10.1021\/acsami.8b05513","journal-title":"ACS Appl Mater Interfaces"},{"key":"5700_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121878","volume":"624","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S, Yasamineh P, Ghafouri Kalajahi H et al (2022) A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm 624:121878. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121878","journal-title":"Int J Pharm"},{"key":"5700_CR67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","volume":"37","author":"S Ding","year":"2020","unstructured":"Ding S, Khan AI, Cai X et al (2020) Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies. Mater Today 37:112\u2013125. https:\/\/doi.org\/10.1016\/j.mattod.2020.02.001","journal-title":"Mater Today"},{"key":"5700_CR68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505\u2013515. https:\/\/doi.org\/10.1021\/mp800051m","journal-title":"Mol Pharm"},{"key":"5700_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"D Owens III","year":"2006","unstructured":"Owens D III, Peppas N (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93\u2013102. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.010","journal-title":"Int J Pharm"},{"key":"5700_CR70","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/10611860400015936","volume":"12","author":"PR Lockman","year":"2004","unstructured":"Lockman PR, Koziara JM, Mumper RJ, Allen DD (2004) Nanoparticle surface charges alter blood\u2013brain barrier integrity and permeability. J Drug Target 12:635\u2013641. https:\/\/doi.org\/10.1080\/10611860400015936","journal-title":"J Drug Target"},{"key":"5700_CR71","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/ACSOMEGA.4C09114\/ASSET\/IMAGES\/MEDIUM\/AO4C09114_0018.GIF","volume":"10","author":"R Tenchov","year":"2025","unstructured":"Tenchov R, Sasso JM, Zhou QA (2025) Evolving landscape of Parkinson\u2019s disease research: challenges and perspectives. ACS Omega 10:1864\u20131892. https:\/\/doi.org\/10.1021\/ACSOMEGA.4C09114\/ASSET\/IMAGES\/MEDIUM\/AO4C09114_0018.GIF","journal-title":"ACS Omega"},{"key":"5700_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES29050957","volume":"29","author":"E Pirunkaset","year":"2024","unstructured":"Pirunkaset E, Boonyarat C, Maneenet J et al (2024) Effect of diacetylcurcumin manganese complex on rotenone-induced oxidative stress, mitochondria dysfunction, and inflammation in the SH-SY5Y Parkinson\u2019s disease cell model. Molecules 29:957. https:\/\/doi.org\/10.3390\/MOLECULES29050957","journal-title":"Molecules"},{"key":"5700_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9193534","volume":"2019","author":"S Nie","year":"2019","unstructured":"Nie S, Ma K, Sun M et al (2019) 7,8-dihydroxyflavone protects nigrostriatal dopaminergic neurons from rotenone-induced neurotoxicity in rodents. Parkinsons Dis 2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/9193534","journal-title":"Parkinsons Dis"},{"key":"5700_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40478-014-0176-9\/FIGURES\/1","volume":"2","author":"RM Gir\u00e1ldez-P\u00e9rez","year":"2014","unstructured":"Gir\u00e1ldez-P\u00e9rez RM, Antol\u00edn-Vallesp\u00edn M, Mu\u00f1oz MD, S\u00e1nchez-Capelo A (2014) Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathol Commun 2:1\u201317. https:\/\/doi.org\/10.1186\/S40478-014-0176-9\/FIGURES\/1","journal-title":"Acta Neuropathol Commun"},{"key":"5700_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167714","volume":"435","author":"V Gao","year":"2023","unstructured":"Gao V, Briano JA, Komer LE, Burr\u00e9 J (2023) Functional and pathological effects of \u03b1-synuclein on synaptic SNARE complexes. J Mol Biol 435:167714. https:\/\/doi.org\/10.1016\/j.jmb.2022.167714","journal-title":"J Mol Biol"},{"key":"5700_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101508","volume":"11","author":"A Picca","year":"2021","unstructured":"Picca A, Guerra F, Calvani R et al (2021) Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson\u2019s disease: roads to biomarker discovery. Biomolecules 11:1508. https:\/\/doi.org\/10.3390\/biom11101508","journal-title":"Biomolecules"},{"key":"5700_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116633","volume":"230","author":"X Li","year":"2024","unstructured":"Li X, Wang W, Pan S et al (2024) Exploring heat shock proteins as therapeutic targets for Parkinson\u2019s disease. Biochem Pharmacol 230:116633. https:\/\/doi.org\/10.1016\/j.bcp.2024.116633","journal-title":"Biochem Pharmacol"},{"key":"5700_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094956","volume":"22","author":"M Rasheed","year":"2021","unstructured":"Rasheed M, Liang J, Wang C et al (2021) Epigenetic regulation of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 22:4956. https:\/\/doi.org\/10.3390\/ijms22094956","journal-title":"Int J Mol Sci"},{"key":"5700_CR79","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM et al (2003) Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 23:10756\u201310764. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-34-10756.2003","journal-title":"J Neurosci"},{"key":"5700_CR80","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","volume":"291","author":"G Park","year":"2016","unstructured":"Park G, Tan J, Garcia G et al (2016) Regulation of histone acetylation by autophagy in Parkinson disease. J Biol Chem 291:3531\u20133540. https:\/\/doi.org\/10.1074\/jbc.M115.675488","journal-title":"J Biol Chem"},{"key":"5700_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIOX12040955","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti S, Bisaglia M (2023) Oxidative stress and neuroinflammation in Parkinson\u2019s disease: the role of dopamine oxidation products. Antioxidants. https:\/\/doi.org\/10.3390\/ANTIOX12040955","journal-title":"Antioxidants"},{"key":"5700_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0294612","volume":"18","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani S, Khoshnam SE, Ghafouri S et al (2023) Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal \u03b1-synuclein and oxidative stress in rotenone-induced Parkinson\u2019s disease of male rats. PLoS ONE 18:e0294612. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0294612","journal-title":"PLoS ONE"},{"key":"5700_CR83","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.2147\/JIR.S468609","volume":"17","author":"M G\u0105ssowska-Dobrowolska","year":"2024","unstructured":"G\u0105ssowska-Dobrowolska M, Olech-Kocha\u0144czyk G, Culmsee C, Adamczyk A (2024) Novel insights into Parkin\u2013mediated mitochondrial dysfunction and \u201cmito-inflammation\u201d in \u03b1-synuclein toxicity. The role of the cGAS\u2013STING signalling pathway. J Inflamm Res 17:4549\u20134574. https:\/\/doi.org\/10.2147\/JIR.S468609","journal-title":"J Inflamm Res"},{"key":"5700_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/life11050371","volume":"11","author":"FB Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves FB, Morais VA (2021) PINK1: a bridge between mitochondria and Parkinson\u2019s disease. Life 11:371. https:\/\/doi.org\/10.3390\/life11050371","journal-title":"Life"},{"key":"5700_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2025.169161","author":"B Basak","year":"2025","unstructured":"Basak B, Holzbaur ELF (2025) Mitophagy in neurons: mechanisms regulating mitochondrial turnover and neuronal homeostasis. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2025.169161","journal-title":"J Mol Biol"},{"key":"5700_CR86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuint.2018.03.001","volume":"117","author":"N Ammal Kaidery","year":"2018","unstructured":"Ammal Kaidery N, Thomas B (2018) Current perspective of mitochondrial biology in Parkinson\u2019s disease. Neurochem Int 117:91\u2013113. https:\/\/doi.org\/10.1016\/j.neuint.2018.03.001","journal-title":"Neurochem Int"},{"key":"5700_CR87","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1089\/ars.2011.4105","volume":"16","author":"K-L Lim","year":"2012","unstructured":"Lim K-L, Ng X-H, Grace LG-Y, Yao T-P (2012) Mitochondrial dynamics and Parkinson\u2019s disease: focus on Parkin. Antioxid Redox Signal 16:935\u2013949. https:\/\/doi.org\/10.1089\/ars.2011.4105","journal-title":"Antioxid Redox Signal"},{"key":"5700_CR88","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antiox12051075","volume":"12","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB (2023) PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants 12:1075. https:\/\/doi.org\/10.3390\/antiox12051075","journal-title":"Antioxidants"},{"key":"5700_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.871357","author":"L Chen","year":"2022","unstructured":"Chen L, Qin Y, Liu B et al (2022) PGC-1\u03b1-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2022.871357","journal-title":"Front Cell Dev Biol"},{"key":"5700_CR90","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.18632\/aging.204353","volume":"14","author":"S Azam","year":"2022","unstructured":"Azam S, Kim I-S, Choi D-K (2022) \u03b1-Synuclein upregulates bim-mediated apoptosis by negatively regulating endogenous GCN5. Aging Albany NY 14:8292\u20138301. https:\/\/doi.org\/10.18632\/aging.204353","journal-title":"Aging Albany NY"},{"key":"5700_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1452696","volume":"2020","author":"S Rius-P\u00e9rez","year":"2020","unstructured":"Rius-P\u00e9rez S, Torres-Cuevas I, Mill\u00e1n I et al (2020) PGC-1 \u03b1, inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev 2020:1\u201320. https:\/\/doi.org\/10.1155\/2020\/1452696","journal-title":"Oxid Med Cell Longev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05700-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05700-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05700-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:17:49Z","timestamp":1769033869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05700-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5700"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05700-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was evaluated and approved by Ege University, Local Ethics Committee for Animal Experiments (Approval No\/Approval Date: 2021- 040\/June 23, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"383"}}